Literature DB >> 28656024

Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.

Florencia McAllister1, Maria F Montiel1, Guneesh S Uberoi1, Angad S Uberoi1, Anirban Maitra1, Manoop S Bhutani1.   

Abstract

It is well known that pancreatic ductal adenocarcinoma has a high mortality rate. Despite progress in understanding the biology and genetic basis of this disease, life expectancy has changed minimally in the last 50 years. This article highlights the importance of screening patients at high risk for developing pancreatic cancer and reviews current methods as well as methods in development for pancreatic cancer early detection and surveillance.

Entities:  

Keywords:  Pancreatic cancer; biomarkers; endoscopic ultrasound; magnetic resonance imaging; screening

Year:  2017        PMID： 28656024      PMCID： PMC5479340     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


  69 in total

1.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

Review 2.  Dual energy CT: preliminary observations and potential clinical applications in the abdomen.

Authors:  Anno Graser; Thorsten R C Johnson; Hersh Chandarana; Michael Macari
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

Review 3.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

Review 4.  Innovations in CT dose reduction strategy: application of the adaptive statistical iterative reconstruction algorithm.

Authors:  Alvin C Silva; Holly J Lawder; Amy Hara; Jennifer Kujak; William Pavlicek
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

5.  Imaging of pancreatic cancer: An overview.

Authors:  Pavan Tummala; Omer Junaidi; Banke Agarwal
Journal:  J Gastrointest Oncol       Date:  2011-09

Review 6.  Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.

Authors:  K S Goonetilleke; A K Siriwardena
Journal:  Eur J Surg Oncol       Date:  2006-11-09       Impact factor: 4.424

7.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

8.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Authors:  P Langer; P H Kann; V Fendrich; N Habbe; M Schneider; M Sina; E P Slater; J T Heverhagen; T M Gress; M Rothmund; D K Bartsch
Journal:  Gut       Date:  2009-05-25       Impact factor: 23.059

Review 9.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review.

Authors:  Eun Sun Lee; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

10.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272
View more
  8 in total

1.  Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome.

Authors:  Maureen Mork; Pompeyo R Quesada; Sarah Bannon; Maria F Montiel; Jason B Fleming; Patrick M Lynch; Manoop S Bhutani; Jeffrey H Lee; Florencia McAllister
Journal:  Pancreas       Date:  2019-04       Impact factor: 3.327

2.  High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.

Authors:  Sarah A Bannon; Maria F Montiel; Jennifer B Goldstein; Wenli Dong; Maureen E Mork; Ester Borras; Merve Hasanov; Gauri R Varadhachary; Anirban Maitra; Matthew H Katz; Lei Feng; Andrew Futreal; David R Fogelman; Eduardo Vilar; Florencia McAllister
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-01

3.  Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer.

Authors:  Qinyu Chen; Daniel R Cherry; Vinit Nalawade; Edmund M Qiao; Abhishek Kumar; Andrew M Lowy; Daniel R Simpson; James D Murphy
Journal:  JCO Clin Cancer Inform       Date:  2021-03

Review 4.  Contemporary Management of Localized Resectable Pancreatic Cancer.

Authors:  Anuhya Kommalapati; Sri Harsha Tella; Gaurav Goyal; Wen Wee Ma; Amit Mahipal
Journal:  Cancers (Basel)       Date:  2018-01-20       Impact factor: 6.639

5.  Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells.

Authors:  Yoshio Sakai; Masao Honda; Shigeyuki Matsui; Osamu Komori; Toshinori Murayama; Tadami Fujiwara; Masaaki Mizuno; Yasuhito Imai; Kenichi Yoshimura; Alessandro Nasti; Takashi Wada; Noriho Iida; Masaaki Kitahara; Rika Horii; Tamai Toshikatsu; Masashi Nishikawa; Hirofumi Okafuji; Eishiro Mizukoshi; Tatsuya Yamashita; Taro Yamashita; Kuniaki Arai; Kazuya Kitamura; Kazunori Kawaguchi; Hajime Takatori; Tetsuro Shimakami; Takeshi Terashima; Tomoyuki Hayashi; Kouki Nio; Shuichi Kaneko
Journal:  Cancer Sci       Date:  2019-03-27       Impact factor: 6.716

6.  RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy.

Authors:  Byunghee Yoo; Veronica Clavijo Jordan; Patrick Sheedy; Ann-Marie Billig; Alana Ross; Pamela Pantazopoulos; Zdravka Medarova
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

7.  Serum N-Glycome analysis reveals pancreatic cancer disease signatures.

Authors:  Gerda C M Vreeker; Randa G Hanna-Sawires; Yassene Mohammed; Marco R Bladergroen; Simone Nicolardi; Viktoria Dotz; Jan Nouta; Bert A Bonsing; Wilma E Mesker; Yuri E M van der Burgt; Manfred Wuhrer; Rob A E M Tollenaar
Journal:  Cancer Med       Date:  2020-09-08       Impact factor: 4.452

Review 8.  Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer.

Authors:  Miles W Grunvald; Richard A Jacobson; Timothy M Kuzel; Sam G Pappas; Ashiq Masood
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.